ClinicalTrials.Veeva

Menu

Ventilation With Supraglottic Airway Devices

R

Reham Ali Abdelhaleem Abdelrahman

Status

Completed

Conditions

Laryngeal Masks Comparison

Treatments

Device: Air-Q Self Pressurized Airway Device with Blocker
Device: Proseal Laryngeal Mask Airway

Study type

Observational

Funder types

Other

Identifiers

NCT04421261
KR-1990

Details and patient eligibility

About

Airo-Q Self Pressurized airway device with Blocker will be compared with Proseal LMA in anesthetized adult female patients undergoing elective surgeries to discuss the influence of different head and neck positions on the performance of both devices. Oropharyngeal leak pressure, peak inspiratory pressure, ventilation score and fiber-optic view will be assessed in neutral, flexion, extension and lateral positions in both groups.

Enrollment

140 patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult female patients ASA I&II.
  • age: 18-55 years old.
  • BMI< 35.
  • undergoing elective surgeries.

Exclusion criteria

  • Patients with history of upper respiratory tract infections and obstructive sleep apnea.
  • Patients who are potentially full stomach such as trauma, pregnancy, history of gastric regurgitation &heart burn, those with esophageal reflux or hiatus hernia.
  • Patients with coagulation disorders.
  • Patients with El-Ganzouri airway score ≥ 5 will.

Trial design

140 participants in 2 patient groups

Air-Q Self Pressurized Airway Device with Blocker
Treatment:
Device: Air-Q Self Pressurized Airway Device with Blocker
Proseal Laryngeal Mask Airway
Treatment:
Device: Proseal Laryngeal Mask Airway

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems